Erika Sugiyama

409 citations

28 papers · 276 indexed · h-index 9

Transplantation
Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacy and Medical Practices 3
- Pharmacogenetics and Drug Metabolism 3
Pharmaceutical Science
- Advancements in Transdermal Drug Delivery 2
Oncology
Pharmacology
- Antibiotics Pharmacokinetics and Efficacy 5
- Pharmacy and Medical Practices 3
- Pharmacogenetics and Drug Metabolism 3
Pediatrics, Perinatology and Child Health
- Pharmaceutical studies and practices 6
Molecular Biology
- Chemical Synthesis and Analysis 2
Gastroenterology
- Gastroesophageal reflux and treatments 2
Pulmonary and Respiratory Medicine
- Renal cell carcinoma treatment 2

Co-authors: Hitoshi Sato Masataka Tajima Kazuo Kobayashi Kenichi Suzuki Akira Ota Takashi Yokokawa Kazunori Mori Toshihiro Hama
Cited by: Transplantation Pharmacology Pharmaceutical Science
Journals: Cancer Chemotherapy and Pharmacology (2 papers)Pharmacology Research & Perspectives (2 papers)Biological and Pharmaceutical Bulletin (2 papers)
Partner nations: Japan Thailand New Zealand

In The Last Decade

Erika Sugiyama

25 papers receiving 271 citations

Peers

Countries citing papers authored by Erika Sugiyama

Since Specialization

Citations

This map shows the geographic impact of Erika Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Sugiyama more than expected).

Fields of papers citing papers by Erika Sugiyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Sugiyama. The network helps show where Erika Sugiyama may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Erika Sugiyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erika Sugiyama Line = papers co-authored together Erika Sugiyama links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development and Stability of a New Transdermal Formulation of Pregabalin for Skin Permeation Biological and Pharmaceutical Bulletin ·Inês X. Martins,Hamidreza Shahbazkia,Masataka Tajima,Detsri Ekarat,Masayuki Yoshikawa,Hitoshi Sato,Erika Sugiyama	2025	0
2	Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma Scientific Reports ·Carolina Guimarães Ayupe,Kenji Nakano,Takeshi Yuasa,Erika Sugiyama,Jason M. Kellhofer,Kazuyuki Ito,朱智文,杨利生,Luo Xiang-y,R.H. Collier,Kazuo Kobayashi,Kenichi Suzuki,Juliana Eichenberger,Masataka Tajima,Hitoshi Sato,Toshihiro Hama,Shunji Takahashi	2023	3
3	Optimal Timing of Intravenous Acetaminophen Administration for Postoperative Analgesia Anesthesia Progress ·Παρασκευή Χασάνη,Akiko Nishimura,Erika Sugiyama,Hitoshi Sato,Takehiko Iijima	2022	1
4	The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death Pharmacological Reports ·Akira Ota,Masataka Tajima,Kazunori Mori,Erika Sugiyama,Hitoshi Sato,Hitoshi Sato	2021	24
5	Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single‐center retrospective observational study Pharmacology Research & Perspectives ·T. Suzuki,Erika Sugiyama,Тамаев Денис Владимирович,Masataka Tajima,Fatima Boutaleb,Masayoshi Yoshii,Kouadio Ibrahime Sinan,Hitoshi Sato,Hitoshi Sato	2021	3
6	Nonlinear Disposition and Metabolic Interactions of Cannabidiol Through CYP3A Inhibition In Vivo in Rats Cannabis and Cannabinoid Research ·Hamidreza Shahbazkia,Daniel Kianpour,Masataka Tajima,Erika Sugiyama,Hitoshi Sato,Aleksey D'Jamirze,Hitoshi Sato	2020	8
7	Association Between Immune-related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell Carcinoma In Vivo ·Kazuo Kobayashi,C. Curé,R.H. Collier,Takashi Yokokawa,Carolina Guimarães Ayupe,اکرم قدیمی,杨利生,Kenichi Suzuki,Hitoshi Sato,Erika Sugiyama,Masataka Tajima,Toshihiro Hama	2020	15
8	Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma Oncology ·Kazuo Kobayashi,Kenichi Suzuki,R.H. Collier,Carolina Guimarães Ayupe,Takashi Yokokawa,اکرم قدیمی,杨利生,C. Curé,Hitoshi Sato,Erika Sugiyama,Masataka Tajima,Toshihiro Hama	2020	21
9	Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer Oncology ·Kazuo Kobayashi,Kazuyoshi Kawakami,Takashi Yokokawa,Carolina Guimarães Ayupe,Kenichi Suzuki,Takeru Wakatsuki,Mitsukuni Suenaga,Hitoshi Sato,Erika Sugiyama,Kensei Yamaguchi,Toshihiro Hama	2019	14
10	Development of a Novel Nanoemulsion Formulation to Improve Intestinal Absorption of Cannabidiol SHILAP Revista de lepidopterología ·Daniel Kianpour,Masataka Tajima,Erika Sugiyama,Hitoshi Sato	2019	77
11	Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer Cancer Chemotherapy and Pharmacology ·Valentina Gorgoglione,Erika Sugiyama,Masataka Tajima,Yasutsuna Sasaki,Seigo Nakamura,V. R. Padole,Dwi Yulis Susanto,Hitoshi Sato,Tadanori Sasaki,Hitoshi Sato	2017	14
12	The Use of 13C–Erythromycin as an in vivo Probe to Evaluate CYP3A-mediated Drug Interactions in Rats Journal of Pharmaceutical Sciences ·Erika Sugiyama,Alex Oguso,Aleksey D'Jamirze,Hitoshi Sato	2011	8
13	Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer Cancer Chemotherapy and Pharmacology ·Yoshinori Makino,Noboru Yamamoto,Hitoshi Sato,Agnieszka Łuków,Yasushi Goto,Chiharu Tanai,Hajime Asahina,Hiroshi Nokihara,Ikuo Sekine,Hideo Kunitoh,Yuichiro Ohe,Erika Sugiyama,Nobuaki Yokote,Tomohide Tamura,Hiroshi Yamamoto	2011	6
14	Estimation of Renal-Excretion Drug Doses Based on Postconceptional Ages in Neonates Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Shinya Suzuki,Gi Nam Yang,Erika Sugiyama,Gujin Liu,Hitoshi Sato	2010	0
15	Approximation Method for Estimating Pediatric Doses of Renal-Excretion Drugs Based on Physiological Development of Renal Function Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Shinya Suzuki,Gi Nam Yang,Erika Sugiyama,Gujin Liu,Hitoshi Sato	2009	2
16	Desirable pharmacokinetic properties of¹³C-uracil as a breath test probe of gastric emptying in comparison with¹³C-acetate and¹³C-octanoate in rats Scandinavian Journal of Gastroenterology ·Erika Sugiyama,Aleksey D'Jamirze,Kolonitskii,I. Kamman,杉田蔵信,Tomislav Budić,Yukihiro Hirao,Hitoshi Sato	2009	1
17	Dose Estimation for Renal-excretion Drugs in Neonates and Infants Based on Physiological Development of Renal Function YAKUGAKU ZASSHI ·Shinya Suzuki,Gi Nam Yang,Erika Sugiyama,Gujin Liu,Hitoshi Sato	2009	7
18	Development of a Drug Information Database Using Hospital LAN for Sharing Information among Physicians, Nurses, and Pharmacists Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·Shinya Suzuki,Gujin Liu,Erika Sugiyama,Hitoshi Sato	2008	1
19	Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients Transplantation Proceedings ·Tsuyoshi Minematsu,Erika Sugiyama,Makiko Kusama,Satoko Hori,Y Yamada,Hisakazu Ohtani,Yasufumi Sawada,Hitoshi Sato,Tatsuya Takayama,Yasuhiko Sugawara,Masatoshi Makuuchi,Tatsuji Iga	2004	31
20	Interaction of Some Plant Heterocyclic .BETA.-Substituted Alanines with Rat Brain N-Methyl-D-aspartate (NMDA) Receptors. Biological and Pharmaceutical Bulletin ·Fumio Ikegami,Kuniko Kusama‐Eguchi,Erika Sugiyama,Kyoko Watanabe,Fernand Lambein,Isamu Murakoshi	1995	14

About Erika Sugiyama

Erika Sugiyama is a scholar working on Pharmacology, Pharmaceutical Science and Pharmacology, having authored 28 papers that have together received 276 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Pharmacy and Medical Practices (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Chemical Synthesis and Analysis (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Gastroesophageal reflux and treatments (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Transplantation (16 citations), Pharmacology (92 citations) and Pharmaceutical Science (21 citations). Erika Sugiyama has collaborated with scholars based in Japan, Thailand and New Zealand. Frequent co-authors include Hitoshi Sato, Masataka Tajima, Hitoshi Sato, Hitoshi Sato, Kazuo Kobayashi, Kenichi Suzuki, Akira Ota, Takashi Yokokawa, Kazunori Mori and Toshihiro Hama. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Pharmacology Research & Perspectives, Biological and Pharmaceutical Bulletin, Oncology and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact